We previously reported reduced blood pressure, psychological symptoms, and other cardiac risk factors in hypertensive patients who participated in a nonpharmacologic, outpatient behavioral program. The present study is a 3 to 5 year follow-up of 59 (60%) of the same patients (who served as their own controls) to assess continued efficacy of the program. At entry into the study, patients had hypertension for a median of 6 years. Therefore, it is unlikely that placebo effect could explain our results. The intervention included training in: elicitation of the relaxation response, nutrition, exercise, and stress management. Comparing measurements taken at the program beginning (pre), end (post) and 3–5 years later (follow-up) showed: (1) reduced systolic blood pressure from pre to follow-up (148–142 mmHg, P < 0.01), with no change from post to follow-up; (2) reduced diastolic blood pressure from pre to follow-up (94–87 mmHg, P < 0.01), with no change from post to follow-up; (3) reduced anxiety, depression and total psychological symptoms on the SCL-90 from pre to follow-up (P < 0.01), with no change from post to follow-up; and (4) increased weight gain from post to follow-up (P < 0.01). Analysis of a subset of patients that could be classified as “never receiving”, “reduced”, or “no change” in medication (N = 24), showed the same reduced blood pressure results. Increased medication use did not account for the long-term efficacy of the intervention.
Nonpharmacologic Intervention for Hypertension Long-Term Foliow-Up
Publication
Journal of Cardiopulmonary Rehabilitation
9(8):p 316-324
Abstract
Web and Email Links
Related Listings
Journal
Behavioral Medicine
The authors assessed data from 1,148 outpatients in a 10-week medical symptom reduction program to determine the effectiveness of a behavioral medicine intervention among somatizing patients. The program included instruction in the relaxation response, cognitive restructuring, nutrition, and exercise. Before and after the intervention, the patients were evaluated on the Symptom Checklist-90 Revised (SCL-90R), the Medical Symptom Checklist, and the Stress Perception Scale. They were di […]
Journal
Annals of the New York Academy of Sciences
Stress is a well-known risk factor in the development of addiction and in addiction relapse vulnerability. A series of population-based and epidemiological studies have identified specific stressors and individual-level variables that are predictive of substance use and abuse. Preclinical research also shows that stress exposure enhances drug self-administration and reinstates drug seeking in drug-experienced animals. The deleterious effects of early life stress, child maltreatment, a […]
Journal
Headache, the Journal of Head and Face Pain
PHYSIOLOGIC CHANGES consistent with the decreased sympathetic nervous system activity are present during the practice of a relaxation technique, Transcendental Meditation. The changes consist of decreased oxygen consumption, carbon dioxide elimination, respiratory rate and minute ventilation. Arterial blood lactate decreases markedly. Arterial blood pH and base excess decrease slightly. There are no changes in arterial blood pressure, in respiratory quotient, nor in rectal temperature […]

